NOF Corporation revised consolidated earnings guidance for the fiscal year ending March 31, 2026. For the year, the company revised net sales of JPY 260,500 million, operating profit of JPY 46,000 million, profit attributable to owners of parent of JPY 39,400 million or JPY 171.21 per share against previous guidance of net sales of JPY 258,400 million, operating profit of JPY 46,000 million, profit attributable to owners of parent of JPY 38,200 million or JPY 166.18 per share.
Reason for revision: The Company has revised its previously announced earnings forecast for the fiscal year ending March 31, 2026, in light of its results for the nine months ended December 31, 2025, and the outlook for the fourth quarter. Earnings from raw materials for DDS in the Pharmaceuticals, Medicals and Health segment are expected to fall below the previously announced forecast due to a decrease in demand, as the market expansion of products by certain customers has been delayed beyond expectation. Earnings from defense-related products in the Explosives & Propulsion segment are expected to exceed the previously announced forecast due to the progress of construction being ahead of expectations in certain transactions related to initial costs for rapid acquisition (contract transactions where revenue is recognized based on the fulfillment of performance obligations). The progress achieved up through the nine months ended December 31, 2025, the demand outlook, the revised exchange rates, etc. suggest that the full-year net sales, ordinary profit, and profit attributable to owners of parent are likely to exceed the previously announced forecast. The expected average exchange rates for the full year in the assumptions on which the earnings forecast is based were revised from the previously announced forecast of 147 yen/U.S. dollar and 170 yen/Euro to 150 yen/U.S. dollar and 173 yen/Euro.
NOF CORPORATION is mainly engaged in the functional chemical products business, life science business and others. The Company operates in three segments. The Functional Chemical segment is engaged in the manufacture and sale of fatty acids, fatty acid derivatives, surfactants, ethylene oxide and propylene oxide derivatives, organic peroxides, petroleum chemicals, functional polymers, functional films, electronic materials and special rust prevention agents, as well as the rust prevention processing. The Life Science segment is engaged in the manufacture and sale of drug formulation materials for drug delivery systems (DDSs), edible oils and fats and health food products, among others. The Chemical segment is engaged in the manufacture and sale of industrial explosives, defense-related items, space-related products. The Company also operates in transportation business and real estate business.
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
